Succinylcholine-induced increases in plasma catecholamine levels in humans

Area of Science:

• Anesthesiology
• Pharmacology
• Cardiovascular Physiology

Background:

• Succinylcholine is a common neuromuscular blocking agent.
• Its interaction with nicotinic receptors and potential to release catecholamines is hypothesized.

Purpose of the Study:

• To investigate the effect of succinylcholine on plasma catecholamine levels.
• To explore the mechanism of catecholamine release and its clinical implications.

Main Methods:

• Plasma levels of epinephrine and norepinephrine were measured before and after intravenous succinylcholine administration in anesthetized patients.
• Measurements were taken at baseline, 2 minutes, and at intervals up to 10 minutes post-injection.
• A control group received metocurine.

Main Results:

• Plasma norepinephrine levels significantly increased from 301 pg/ml to 491 pg/ml 2 minutes after succinylcholine injection (P < 0.01).
• Norepinephrine levels peaked around 3 minutes and returned to baseline by 10 minutes.
• Plasma epinephrine levels did not change significantly; metocurine had no effect on catecholamine levels.

Conclusions:

• Succinylcholine administration leads to a significant, transient increase in plasma norepinephrine.
• This elevation may be mediated by stimulation of nicotinic receptors on sympathetic nerve terminals.
• Increased norepinephrine may contribute to adverse cardiovascular events associated with succinylcholine use.